| 1 |
Christopher Sean Straub |
Novartis Ag |
5 |
| 2 |
Russell C. Petter |
Bristol-Myers Squibb |
3 |
| 2 |
Andrew H. Fischer |
University Of Massachusetts |
3 |
| 2 |
Edward D. Kingsley |
Performance Indicator |
3 |
| #5 |
John A. Greszczuk |
Tq Delta |
2 |
| #5 |
Atli Thorarensen |
Pfizer |
2 |
| #5 |
John Dimitriou |
C.R. Bard |
2 |
| #5 |
David J. Lauffer |
Vertex Pharmaceuticals Incorporated |
2 |
| #5 |
Ashis Saha |
Asana Biosciences |
2 |
| #5 |
Donald B. Rising |
Millipore |
2 |
| #5 |
Sylvia Messier |
Danaher |
2 |
| #5 |
Robert Anselmo |
Lutron Electronics Co. |
2 |
| #5 |
Christopher Buck |
Lutron Electronics Co. |
2 |
| #5 |
John E. Meschter |
Polaroid |
2 |
| #5 |
Heinz Bachmann |
Blackberry Limited |
2 |
| #5 |
Ravi Pattabhi |
Oracle |
2 |
| #17 |
Thomas E. Westberg |
Rovi Guides |
1 |
| #17 |
Anna M. Galea |
Vivonics |
1 |
| #17 |
Ulrich Hans Thomann |
T2 Biosystems |
1 |
| #17 |
Andrew Cook |
Constellation Pharmaceuticals |
1 |
| #17 |
Keith H. Acosta |
Bose |
1 |
| #17 |
Gregory Pitarys |
Axis Semiconductor |
1 |
| #17 |
E. Evert Basch |
Verizon |
1 |
| #17 |
H. Eric Sonnichsen |
Test Devices |
1 |
| #17 |
Thomas C. Porcher |
Digital Equipment |
1 |
| #17 |
Robert W. Toop |
Emc |
1 |
| #17 |
Patrick S. King |
Cisco |
1 |
| #17 |
Carey J. McMaster |
Sepaton |
1 |
| #17 |
Michael W. Hamblin |
Teradyne |
1 |
| #17 |
Andrew Goldman |
Formlabs |
1 |
| #17 |
William Goddin |
IBM |
1 |
| #17 |
Gregory Raymond Bebernitz |
Novartis Ag |
1 |
| #17 |
Carol R. Peo |
Sas Institute |
1 |
| #17 |
Sujin Catherine Chang |
Verizon |
1 |
| #17 |
Tony Fleming |
Novartis Ag |
1 |
| #17 |
James Neef |
Novartis Ag |
1 |
| #17 |
Louis J. Rota, Jr. |
Flir Systems |
1 |
| #17 |
Edwin B. Merrick |
— |
1 |
| #17 |
Scott L. Hills |
Aware |
1 |
| #17 |
Todd S. Vangness |
Nypro |
1 |
| #17 |
Gregory Donald Troxel |
RTX (Raytheon) |
1 |
| #17 |
Burak Say |
Onepin |
1 |
| #17 |
Kyle Jarger |
Codman & Shurtleff |
1 |
| #17 |
David S. Millan |
Forma Therapeutics |
1 |
| #17 |
Reinhard Schumann |
Digital Equipment |
1 |
| #17 |
Travis Stams |
Novartis Ag |
1 |
| #17 |
Steve Lang |
HP |
1 |
| #17 |
Stephen D. Milligan |
Bbn Technologies |
1 |